Therapy Areas: AIDS & HIV
15 May 2019 - - US-based biopharmaceutical company Gilead Sciences, Inc. (NASDAQ: GILD) will donate Truvada for PrEP (emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg tablets) to the...
15 May 2019 - It was reported yesterday that the US Food and Drug Administration (USFDA) has granted breakthrough therapy designation to United States-based Celgene's Pomalyst (pomalidomide) inte...
1 May 2019 - United Kingdom-based ViiV Healthcare is seeking approval from the US Food and Drug Administration (FDA) for the investigational, monthly, injectable, two-drug regimen of cabotegravir and ...
30 April 2019 - - UK-based specialist HIV company ViiV Healthcare, which is majority owned by GSK, with Pfizer Inc. and Shionogi Ltd. as shareholders, has submitted a New Drug Application to the US Fo...
18 April 2019 - - US-based nonprofit charitable organisation CDISC and the nonprofit organization Critical Path Institute (C-Path) have released a global Therapeutic Area Standard that specifies how t...